Investee Company Update: Nuuvera

RNS Number : 1639B

FastForward Innovations Limited

08 January 2018

 

8 January 2018

FastForward Innovations Limited

("FastForward"")

Investee Company Update: Nuuvera listing delayed to 9^th January 2018

FastForward announces that it has been informed by investee company Nuuvera Corp ("Nuuvera" or "the Company"), a privately held company formed to capitalize on the global secular trend towards the legalization of cannabis, in which FastForward has a holding of 3.75%, that it expects to release the following announcement in Canada later today:

"Due to a clerical error at the TSX, Nuuvera Inc. ("Nuuvera")(TSXV : NUU) was advised by TSX this morning that it will be open for trading at the market open on Tuesday, January 9, 2018, and not on Monday, January 8, 2018, as previously announced. Nuuvera has been assured by the TSX that the 24-hour delay has been solely caused by TSX itself and in no way reflects any change in Nuuvera's status as a listed issuer on TSX Venture Exchange in good standing.

In connection with the trading delay, Ungad Chadda, President, Capital Formation, Toronto Stock Exchange, TSX Venture Exchange, provided the following statement to Nuuvera and its shareholders:

"We are honoured to have Nuuvera join the TSX Venture Exchange and want to assure the public that Nuuvera has been formally approved as a listed company on TSX Venture Exchange. We also take this opportunity to apologize to Nuuvera and its stakeholders on the delayed first day of trading which was caused by a clerical error. Nuuvera will be available for trading at the open on Tuesday, January 9, 2018, and we look forward to hosting the Nuuvera team to open the market this Wednesday, January 10, 2018 to celebrate their listing."

In response to these events, the President and CEO of Nuuvera, Lorne Abony, issued the following statement:

"We thank TMX for taking steps to expeditiously resolve this issue, so that Nuuvera can begin trading as quickly as possible. While we are disappointed that we will not begin trading on Monday, as planned, we know that success in our growing industry is all about the long term. Nuuvera has the strategy, team and perspective to create long term success, and to approach this industry in a responsible way. We are eager to provide investors with the opportunity to join us on this mission."

About Nuuvera

Nuuvera is a global cannabis company founded on Canadian principles, and built with the whole world in mind. Nuuvera is currently working with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. Through its subsidiaries, ARA - Avanti Rx Analytics Inc. and Avalon Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the Narcotic Control Regulations and Office of Controlled Substances. Nuuvera is currently in the final stages of the Health Canada review process to become a Licensed Producer of medical marijuana under the ACMPR, and has recently received its "letter to build" approval.

For further information please visit www.fstfwd.co or contact:

FastForward  Innovations Limited [e-mail]   Sue Saunders/ Ian Burns

Beaumont Cornish Limited (Nomad) Tel: [phone] James Biddle / Roland Cornish

Optiva Securities Limited (Broker) Tel: [phone] Ed McDermott

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

END

 

 

UPDUBSWRWVAARAR